Brent Zettl is President and CEO of Zyus Life Sciences which is focused on advancing the science of wellbeing. In their 18 years of study they research the use of cannabis as treatment for; chronic and neuropathic pain, and for, neopsychology research into depression, anxiety and PTSD. They advanced from anecdotal evidence from patients to a more clinical setting study. Prior prohibition, 28% in a doctor’s toolkit were cannabis based. Prohibition wiped out this treatment. Some 80 years later, clinical evidence is leading to more discoveries into the benefits from these medications that were disallowed. Mr. Zettl brings us up to date on the process of research and what they are finding.
Find more at :https://w420radionetwork.com/s2-e18-10-tips-for-business-after-covid-post-legalization-business-research-clinical-studies-on-cannabis-medical-practice-changes-in-the-pandemic/
